aTHermaVac - a Therapeutic Herpes Simplex Type 2 mRNA Vaccine
Reference number | |
Coordinator | Eurocine Vaccines AB |
Funding from Vinnova | SEK 0 |
Project duration | May 2024 - April 2026 |
Status | Completed |
Venture | Swelife - Collaboration project for better health |
Call | Swelife - Collaborative projects for better health autumn 2023 |